• UAE-based healthtech startup Alma Health has raised a $10 million Series A funding round co-led by Knuru Capital and Hambro Perks Oryx Fund, with participation from e& capital, S3 Ventures, Pinnacle Capital, and Khwarizmi Ventures.
• Founded in 2021 by Tariq Seksek and Khaldoon Bushnaq, Alma Health is a direct-to-patient digital healthcare company catering to people with chronic conditions.
• The company, which currently operates in the UAE, Saudi Arabia, and Egypt, plans to use the new funding to accelerate its growth in Saudi Arabia, enter new markets, and continue to hire talent.

Source: Forbes

UAE-based direct-to-patient digital healthcare company Alma Health has raised $10 million in a Series A funding round co-led by Knuru Capital and Hambro Perks Oryx Fund.

The fundraising round witnessed participation from e& Capital, S3 Ventures, Pinnacle Capital, and Khwarizmi Ventures, with KCP Capital acting as the financial advisor to the company.

The company currently operates in the UAE, Saudi Arabia, and Egypt, and it plans to use the new funding to accelerate its growth in Saudi Arabia, enter new markets, and continue to hire top talent. It will also continue its mission to become one of the leading direct-to-patient healthcare providers specialized in chronic condition management.

Established in 2021 by Tariq Seksek and Khaldoon Bushnaq, Alma Health provides healthcare services to people with chronic conditions.

It offers virtual doctor consultations directly via its application with one of the company’s licensed in-house physicians.

In addition, Alma Health offers at-home lab tests, automatic prescription renewals, and home delivery of prescription medicines without any additional cost.

Patients can also benefit from a second opinion on their chronic condition and a customized management plan to improve clinical outcomes.

“Alma Health is truly blessed to have touched and improved the lives of many people living with chronic conditions in the MENA region," Alma Health Co-founder Tariq Seksek said in a statement to Forbes Middle East.

"We need to continue to innovate on our end-to-end health-tech solution with the patients at the heart of the experience."